Key facts
- The primary owner of Novo Nordisk is establishing research incubators throughout Europe.
- The initiative aims to translate academic findings into commercial products.
- The focus is on developing treatments for obesity and diabetes.
The primary owner of Ozempic maker Novo Nordisk is establishing research incubators throughout Europe. This initiative aims to translate academic findings into commercial products for obesity and diabetes treatment.